MR imaging features and tumor biomarkers of screen-detected and non-screen detected breast cancers: Preliminary results of a comparative study
Clinical Imaging Aug 30, 2018
Panourgias E, et al. - Researchers conducted the study for examining differences in clinical features, MRI findings and tumor biomarker characteristics in screen-detected (SCD) and non-screen detected (NSCD) cancers. By two expert radiologists, 62 women (mean age, 48.4 years; range, 33–68 years) with biopsy confirmed breast cancer who had preoperative breast MRI were retrospectively assessed. They observed that NSCD cancers had a higher prevalence of poor prognostic characteristics in comparison to SCD tumors, including larger tumor size, higher Ki-67 index, and positive nodes. Compared to SCD breast cancers, increased fibroglandular tissue and background parenchymal enhancement (BPE) were strongly related to NSCD cancers and supporting their use as potential MR biomarkers in breast cancer risk models.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries